✦ LIBER ✦

Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008

✍ Scribed by Rachel F DEAR; Patrick J KELLY; Gavin M WRIGHT; Paul STALLEY; Brian C MCCAUGHAN; Martin HN TATTERSALL

Book ID: 114829940
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 180 KB
Volume: 8
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2012.01521.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of venous thromboembolism in bone a

Risk of venous thromboembolism in bone and soft-tissue sarcoma patients undergoing surgical intervention: A report from prior to the initiation of SCIP measures

✍ Timothy A. Damron; Zabi Wardak; Bradley Glodny; William Grant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract ## Background and Objectives This study reviews incidence and risk factors for venous thromboembolism (VTE) in bone/soft‐tissue sarcoma patients prior to the initiation of Surgical Care Improvement Program (SCIP) measures in October 2009. ## Methods A retrospective chart review ident

Prognostic and predictive factors for ou

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

✍ Stefan Sleijfer; Monia Ouali; Martine van Glabbeke; Anders Krarup-Hansen; Sjoerd 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB

9403 Eribulin mesylate (E7389) in patien

9403 Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC 62052)

✍ Schöffski, P.; Hartmann, J.T.; Hohenberger, P.; Krarup-Hansen, A.; Wanders, J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB